As of June 21, 2025, Hexo Corp (HEXO.TO) reports a EV/EBITDA of -0.86.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Hexo Corp's EV/EBITDA to Peers
To better understand Hexo Corp's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Hexo Corp (HEXO.TO) | -0.86 |
| Harrow Health Inc (HROW) | 38.52 |
| BioDelivery Sciences International Inc (BDSI) | 9.66 |
| Knight Therapeutics Inc (GUD.TO) | 9.35 |
| High Tide Inc (HITI.V) | 9.26 |
| cbdMD Inc (YCBD) | 9.15 |
Compared to its competitors, Hexo Corp's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.